Social

Twitter - TXManufacturers

Facebook - Texas Association of Manufacturers

Packaging manufacturer inks deal for new $50M facility in Rockwall - Dallas Business Journal

bizjournals.com

Paper and plastics manufacturer Lollicup USA Inc. has signed a deal that will make way for the development of a $50 million, 700,000-square-foot manufacturing facility in Rockwall, which will help it expand its logistics capabilities in this part of the country.

#ManufacturingMatters Here's the latest big news coming out of North Texas.

We Work for Health Texas

Today marks a major victory for patients everywhere. The U.S. House of Representatives has reauthorized the Prescription Drug User Fee Act (PDUFA), which provides the FDA the resources they need to review life-saving therapies in an efficient and timely manner. For the last 25 years, PDUFA has helped move many medicines through the drug approval process, allowing patients to quickly access them. We sincerely thank all of the lawmakers who stood by patients today with their vote and leadership. This action will help save countless lives and help patients now and in the future. #CuresNow

Good news for patients and for the biopharmaceutical manufacturing sector!

Lawmakers in Washington are currently discussing re-authorization of the Prescription Drug User Fee Act (PDUFA), which provides critical funding to help ensure the U.S. Food and Drug Administration has necessary resources to efficiently review and approve new medicines. Since it was first passed in 1992, PDUFA has helped to bring more than 1,500 new medicines to patients in need. That's why pharmaceutical manufacturers agree that we need to tell Congress PDUFA is critical to promoting timely access to safe and effective medicines.

For 25 years, the Prescription Drug User Fee Act (PDUFA) has provided critical funding to the U.S. Food and Drug Administration to ensure it has the tools, resources and staff to efficiently review and approve new medicines -- an issue important to the biopharmaceutical and manufacturing industry here in Texas. Congress is working now to reauthorize this important legislation to support the FDA and continue fostering scientific innovation. Make your voice heard and tell Congress PDUFA is vital to bringing new medicines to patients in need.